Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
13C10-retinyl acetate is a stable isotope-labeled analog of retinyl acetate (Vitamin A) used primarily as a metabolic tracer in clinical research to assess Vitamin A status and absorption. By incorporating ten Carbon-13 atoms into the retinyl acetate molecule, researchers can distinguish the administered dose from endogenous Vitamin A using mass spectrometry techniques such as gas chromatography-combustion-isotope ratio mass spectrometry (GC-C-IRMS). In studies led by the University of Colorado, Denver, it is employed to evaluate the impact of Environmental Enteric Dysfunction (EED) on nutrient absorption in pediatric populations. The tracer follows the same metabolic pathways as dietary Vitamin A, being absorbed in the intestine and converted to retinol, which allows for the precise quantification of total body stores and fractional absorption efficiency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 13C10-retinyl acetate.